A61K 31/255
Of sulfoxy acids or sulfur analogues thereof
Official title: of sulfoxy acids or sulfur analogues thereof
A61K31/255 (Of sulfoxy acids or sulfur analogues thereof) appears on 345 US grants and 494 published applications in this corpus.
Search patents in A61K- Granted patents
- 345
- Published applications
- 494
- Assignees
- 336
- Inventors
- 1,025
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 6 | 0 |
| 1981 | 2 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 4 | 0 |
| 1986 | 2 | 0 |
| 1987 | 0 | 0 |
| 1988 | 3 | 0 |
| 1989 | 3 | 0 |
| 1990 | 2 | 0 |
| 1991 | 4 | 0 |
| 1992 | 1 | 0 |
| 1993 | 5 | 0 |
| 1994 | 1 | 0 |
| 1995 | 6 | 0 |
| 1996 | 1 | 0 |
| 1997 | 6 | 0 |
| 1998 | 8 | 0 |
| 1999 | 8 | 0 |
| 2000 | 17 | 0 |
| 2001 | 9 | 2 |
| 2002 | 11 | 17 |
| 2003 | 8 | 21 |
| 2004 | 5 | 19 |
| 2005 | 7 | 25 |
| 2006 | 12 | 17 |
| 2007 | 5 | 15 |
| 2008 | 5 | 14 |
| 2009 | 5 | 11 |
| 2010 | 6 | 13 |
| 2011 | 5 | 19 |
| 2012 | 6 | 11 |
| 2013 | 8 | 15 |
| 2014 | 4 | 29 |
| 2015 | 9 | 21 |
| 2016 | 20 | 31 |
| 2017 | 20 | 27 |
| 2018 | 14 | 26 |
| 2019 | 27 | 26 |
| 2020 | 14 | 21 |
| 2021 | 11 | 24 |
| 2022 | 17 | 22 |
| 2023 | 9 | 21 |
| 2024 | 5 | 15 |
| 2025 | 14 | 12 |
| 2026 | 6 | 20 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions for disrupting biofilm formation and for treating biofilm-related disorders18 Aug 2026US 12,708,612 B2AHV International B.V.
- Compositions and methods for treating amyotrophic lateral sclerosis2 Jun 2026US 12,644,122 B2Children's Medical Center Corporation
- Treatment of Krabbe disease with umbilical cord blood transplantion (UCBT) and increased galactocerebrosidase (GALC) expression14 Apr 2026US 12,599,636 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Methods and compositions for reconstituting microglia17 Mar 2026US 12,576,110 B2Children's Medical Center Corporation
- Compounds and uses thereof17 Feb 2026US 12,552,775 B2Foghorn Therapeutics Inc.
- Stem cell-derived ecto-liposome fusion nanoparticles and use thereof10 Sep 2026US 2026/0263362 A1Ectosome Inc.
- Aryl hydrocarbon receptor agonist prodrugs and methods of use thereof10 Sep 2026US 2026/0263431 A1Allianthera Boston Inc.
- Carbamoyl phenylalaninol compounds as taar1 agonists3 Sep 2026US 2026/0256729 A1Axsome Therapeutics, Inc.
- Methods of treating uterine fibroids27 Aug 2026US 2026/0248803 A1Northwestern University
- Methods of treating pancreatic cancer27 Aug 2026US 2026/0250684 A1The Regents of the University of California
Most cited
By later US patents
- Bone marrow transplantation103US 5,806,529 AYeda Research and Development Co. Ltd. · 1998
- Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically proliferating cells or to upregulate nitrosative stress defenses90US 6,057,367 ADuke University · 2000
- Combination therapy comprising anti-diabetic and anticonvulsant agents65US 6,686,337 B2Ortho-McNeil Pharmaceutical, Inc. · 2004
- Method for treating obesity56US 7,109,198 B2Duke University · 2006
- Safe and effective biofilm inhibitory compounds and health-related uses thereof54US 7,087,661 B1Cernofina, LLC · 2006